Predictable risk factors in children with acute lymphoblastic leukemia

Area of Science:

• Pediatric Oncology
• Hematology
• Leukemia Research

Background:

• Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.
• Identifying prognostic factors is crucial for tailoring treatment strategies.
• Previous studies highlighted age and initial white blood cell (WBC) count as key indicators.

Purpose of the Study:

• To analyze predictable prognostic factors in pediatric acute lymphoblastic leukemia (ALL).
• To evaluate the significance of initial WBC count and cell kinetics in newer treatment protocols.
• To explore the utility of glucocorticoid receptor (GR) expression for prognostic prediction.

Main Methods:

• Retrospective analysis of 174 children with ALL treated over ten years.
• Evaluation of prognostic factors including age, T-cell marker, initial WBC count, and cell kinetics.
• Measurement of glucocorticoid receptor (GR) levels on leukemic cells.

Main Results:

• Children under 1 year and those with T-cell ALL markers showed a poor prognosis.
• Initial WBC count > 50,000/mm3 was less significant with newer chemotherapy protocols.
• Glucocorticoid receptor (GR) levels provided more accurate prognostic prediction than initial WBC or cell kinetics.
• Poor prognosis was observed in children with initial WBC > 50,000/mm3 and GR < 20,000 sites/cell.

Conclusions:

• Age and T-cell marker status remain critical prognostic indicators in childhood ALL.
• Glucocorticoid receptor (GR) expression is a valuable tool for predicting treatment outcomes in ALL.
• Combining initial WBC count with GR levels enhances prognostic accuracy for high-risk patients.